Luye Pharma Group Ltd. ( LYPHF) - Key Metrics
LYPHF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.74 | $0.10 | $0 | $0 |
| 2025Q4 | $0.76 | $0.07 | $0.09 | $0.10 |
| 2025Q2 | $0.85 | $0.08 | $0.47 | $0.47 |
| 2024Q4 | $0.79 | $0.02 | $0.15 | -$0.30 |
| 2024Q2 | $0.82 | $0.10 | -$0.10 | -$0.10 |
LYPHF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 3.59 |
| 2025Q4 | 0% | 9.21 |
| 2025Q2 | 0% | 5.77 |
| 2024Q4 | 0% | 31.36 |
| 2024Q2 | 0% | 6.72 |
LYPHF
Price: $0.27
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 27
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.1 billion